Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-036005
Filing Date
2014-11-10
Accepted
2014-11-10 16:45:15
Documents
2
Period of Report
2014-11-06

Document Format Files

Seq Description Document Type Size
1 rrd418707.html 3  
1 rrd418707.xml 3 2158
2 POA DOCUMENT rrd377000_427057.htm EX-24.3 3162
  Complete submission text file 0001181431-14-036005.txt   6779
Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

EIN.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HORIZON PHARMA PLC ADELAIDE CHAMBERS, PETER STREET DUBLIN 8 L2 NONE
Business Address
Kelly David George (Reporting) CIK: 0001624670 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35238 | Film No.: 141209292